Combinent BioMedical Systems, Inc. Receives Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7567bcf-2bf6-47d3-a1bc-3783ad0ff57f&Preview=1 -
Date
5/7/2007 -
Company Name
Combinent BioMedical Systems, Inc. -
Mailing Address
420 Bedford Street Lexington, MA 02420 -
Company Description
Combinent BioMedical Systems, Inc. is an emerging specialty pharmaceutical company that is developing novel drug combinations and formulations of existing pharmaceutical products using its proprietary transvaginal drug delivery system (TVDS). Combinent has targeted both local and systemic deliveries of existing pharmaceuticals to support a wide variety of conditions selectively affecting women. Licensees and co-developers are provided with full capabilities in product formulation, development, regulatory, and manufacturing. Combinent’s first series of proprietary products are directed at alternate combinations of three hormones for the treatment of endometriosis, polycystic ovarian disease, and hormone replacement therapy or as a novel contraceptive with or without microbicides for the prevention of HIV, HBV HPV and/or HSV transmission. -
Website
http://www.combinentbms.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Series A -
Proceeds Purposes
This financing will be used primarily to fund clinical trials. -
M&A Terms
-
Venture Investor
Cytyc Development Company -
Venture Investor
VIMAC Ventures -
Venture Investor
Commons Capital
